BioBuzz, the media outlet of Workforce Genetics, and the Frederick Innovative Technology Center, Inc. (FITCI) have announced a partnership to fuel strategic industry growth in the BioHealth Capital Region and growth for both parties.
Frederick, Maryland, continues to prove why it’s the perfect place to start, grow, or expand a life sciences company. Over the last 18 months, Frederick City and Frederick County have seen immense growth in the life sciences and biotech spaces, even in the face of nationwide economic challenges.
The Geneva Foundation (Geneva), a nonprofit leader in advancing military medicine, today announced the opening of its new office in Frederick, Maryland at the Frederick Innovative Technology Center, Inc. (FITCI), in collaboration with the Frederick County Office of Economic Development (FCOED). The location will serve as Geneva’s Frederick-based research management office as the organization continues to deliver medical research solutions to the Department of Defense (DoD).
Forecyte Bio, a leading China-based CDMO biotech company, recently celebrated the grand opening of its new facility in Frederick County, Maryland. The 17,000 square foot location is dedicated to contract development and manufacturing for the rapidly growing Cell and Gene Therapy industry. The facility aims to provide a “one-stop” holistic service package to help accelerate clients’ projects from early concept to commercial manufacturing.
BioFactura is joining forces with Rani Therapeutics Holdings, Inc. to assess BioFactura’s BFI-751 biosimilar Stelara (ustekinumab) candidate with Rani’s RaniPill platform technology, which intends to replace subcutaneous or intravenous injection of biologics with pain-free oral dosing, in the form of a ‘robotic’ pill.
According to the California-based biotech, the RaniPill platform technology enables the drug to navigate through the patient’s stomach and enter the small intestine. The RaniPill capsule then goes through a transformation and aligns itself to inject the drug into the intestinal wall.
Hood College in Frederick to Bolster Biomedical Research and Training Center with matching MD Department of Commerce Grant Hood College among eight local colleges, universities who raised matching funds to [….]
The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, joined Maryland Governor Larry Hogan Wednesday at AstraZeneca’s Frederick Manufacturing Center, a Maryland-based biologics manufacturing center for a facility tour and discussion of BioHub Maryland, MTC’s life science workforce development initiative.
Located in the northern part of Maryland along the I-270 Technology Corridor, Frederick County is home to more than 80 bioscience companies. With proximity to Fort Detrick, home to the Frederick National Laboratory for Cancer Research, the county boasts a powerful environment of life sciences intellectual prowess.
Over a period of four days, life sciences companies from across the globe will descend on San Diego for the annual Biotechnology Innovation Organization (BIO) meeting. Multiple companies from Maryland, as well as the Department of Commerce, will be among them, showcasing the strength of the BioHealth Capital Region.
An impact investor can be an individual or investment fund that has co-equal primary goals: to make money and foment positive social change that can last. In some ways, impact investors are “social VCs”—they fund projects and companies that can create positive, measurable impact for the greater good of humanity. Unlike traditional VC investment strategies that tend to take a high risk, high reward approach, impact investing generally focuses on lower risk, more modest or conservative financial investments that yield the most possible good for people and communities.
